Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 2.91
- Piotroski Score 5.00
- Grade Outperform
- Symbol (HAE)
- Company Haemonetics Corporation
- Price $85.90
- Changes Percentage (-0.73%)
- Change -$0.63
- Day Low $84.96
- Day High $87.61
- Year High $97.97
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; and Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/06/2025
- Fiscal Year End N/A
- Average Stock Price Target $114.00
- High Stock Price Target $120.00
- Low Stock Price Target $85.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $2.29
- Trailing P/E Ratio 37.38
- Forward P/E Ratio 37.38
- P/E Growth 37.38
- Net Income $117.56 M
Income Statement
Quarterly
Annual
Latest News of HAE
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Michael Jordan and fellow team owners vs. NASCAR in less than 60 seconds
Michael Jordan and other team owners are taking NASCAR to court over its charter system, claiming it restricts team autonomy. A verdict is anticipated as NASCAR's championship weekend starts....
By AP NEWS | 19 hours ago -
4 New Netflix Holiday Movies to Add to Your Must-Watch List This Month -- Including One Where Chad Michael Murray Bares It All
Netflix is releasing the holiday movie "Meet Me Next Christmas" in November. Christina Milian's character, Layla, seeks a ticket to a Pentatonix concert to find love. With the help of a personal conci...
By PEOPLE.com | 1 day ago -
Archaeologists make remarkable discovery of 4,000-year-old town...
Archeologists discovered a 4,000-year-old Bronze Age town named al-Natah in a Saudi Arabian oasis, providing evidence of the region's transition from nomadic to urban living....
By New York Post | 1 day ago
